Skip to main content

Three-week ileostomy closure after colorectal surgery: a multicenter randomized trial of technical and postoperative outcomes

In brief

Three-week ileostomy closure cuts surgery time by 40 minutes in selected patients

In a randomized trial of 224 patients with confirmed healing, closure at 3 weeks took 90 minutes on average, versus 130 minutes with delayed closure, and fewer patients needed extended adhesiolysis. Short-term complications and other postoperative outcomes were similar; 3.6% had a brief delay in chemotherapy. The results support early closure for carefully selected patients, but not without confirming anastomotic healing.

Journal
Techniques in coloproctology (Q1)
Published
27 October 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Y Debakey, M S Mostafa, A Kilany, A Madkour, A R Mohamed, A El-Mikkawy, et al.
PMID
42944996
DOI
10.1007/s10151-026-03416-3

Why clinicians should know about it

  • Picked for Gastroenterology (top studies of the week, 1 November 2026): Early ileostomy closure reduces operative duration
  • Picked for Surgery (top studies of the week, 1 November 2026): Randomized trial informs timing and outcomes of ileostomy reversal

Abstract

BACKGROUND: The optimal timing of temporary ileostomy closure following restorative colorectal surgery remains controversial. Although previous randomized studies have demonstrated the feasibility of early closure in carefully selected patients, the influence of closure timing on operative complexity has not been prospectively evaluated. This multicenter randomized controlled trial compared a standardized 3-week ileostomy closure strategy with conventional delayed closure, with particular emphasis on technical and postoperative outcomes. METHODS: In this prospective multicenter randomized controlled trial, 224 patients undergoing restorative colorectal resection with temporary diverting ileostomy were randomized to either early ileostomy closure at 3 weeks (n = 112) or conventional delayed closure (n = 112). Eligibility for reversal required rigorous confirmation of anastomotic healing using standardized clinical and endoscopic assessment, with selective computed tomography using rectal contrast when clinically indicated. The primary outcome was operative complexity, evaluated using operative duration, intraoperative adhesion severity, and the requirement for extended adhesiolysis. Secondary outcomes included postoperative morbidity, Clavien-Dindo complication grade, length of hospital stay, readmission, reoperation, re-diversion, and delay in adjuvant chemotherapy. RESULTS: Baseline demographic, clinical, and operative characteristics were comparable between the study groups. Early ileostomy closure was associated with significantly shorter operative duration (90 ± 12 vs. 130 ± 18 min; P < 0.001), substantially lower intraoperative adhesion severity (P = 0.04), and a markedly reduced requirement for extended adhesiolysis (5.4% vs. 21.4%; P < 0.001). Overall postoperative morbidity, Clavien-Dindo grade distribution, postoperative length of stay, readmission, reoperation, and mortality were comparable between groups. Delays in adjuvant chemotherapy occurred only in the early-closure group (3.6%), were limited to 1-4 weeks, and all affected patients subsequently commenced the planned oncologic treatment. CONCLUSIONS: In carefully selected patients with confirmed anastomotic healing, 3-week ileostomy closure is a technically feasible and safe strategy following restorative colorectal surgery. Compared with conventional delayed closure, reversal at 3 weeks significantly reduced operative complexity without compromising short-term postoperative outcomes. These findings support selective implementation of a standardized 3-week ileostomy closure strategy and identify operative complexity as a key determinant when selecting the optimal timing of ileostomy reversal. GOV IDENTIFIER: NCT05192018.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.